Can Security Impede Innovation? How AIS Engage Transformed Login Chaos Into Single-Sign-On Success
- Edan Harr
- Feb 7
- 8 min read
Updated: Feb 11
While AIS Engage transformed login chaos into single-sign-on success, I discovered a few key insights on how humans interact with security barriers.
"Your session has expired. Please authenticate to gain access or contact your site administrator" flashed across the Global Operations Director's screen. The Director at the leading pharmaceutical firm stared at her fourth login attempt of the morning- the company's internal systems had become a maze of authentication barriers, with employees locked out of critical resources dozens of times per month.
The modern enterprise faces a paradox: they've invested millions in digital transformation while their employees still juggle dozens of credentials across siloed systems. Picture a Fortune 500 pharmaceutical company where employees waste hours navigating between seven different portals just to access basic drug information, clinical guidelines, and compliance documentation. When they approached us to build an AI assistant to automate information lookup for their internal knowledge base- something to help employees quickly access drug information as well as automate refill notifications- we discovered their help desk spent 600+ hours monthly on password resets alone.
The disconnect ran deeper than inconvenience. The pharmaceutical company had state-of-the-art research facilities and cutting-edge clinical trials, yet their internal systems remained fragmented and isolated. Building an effective AI assistant would require seamless access to multiple knowledge bases, compliance systems, and employee portals. But how could an AI assistant help employees find information when it couldn't even reliably determine who was asking the question?
This authentication gap created cascading failures throughout pharmaceutical operations. Research teams lost access to time-sensitive trial data. Regulatory compliance officers struggled to maintain audit trails across fragmented systems. Meanwhile, IT departments faced an impossible challenge: securing an enterprise where each system had its own identity silo. Traditional Single Sign-On (SSO) solutions, designed for simpler corporate environments, crumbled under the weight of pharmaceutical industry's complex regulatory and compliance requirements.

The Login Labyrinth: Compliance Turned Chaos
Day one of our discovery phase revealed a reality far more complex than "just another SSO project." In a conference room filled with system diagrams, the pharmaceutical company's IT Director pulled up what they called their "authentication map." If it wasn’t telling enough that they needed a slide deck to explain their database structure, it looked more like a Jackson Pollock painting than a system architecture- arrows crisscrossing between 14 different authentication systems, three separate Active Directories, and a maze of outdated legacy applications.
The first major hurdle emerged during our initial attempt to map the API integrations needed for the bot. To answer even basic questions like "What's the recommended dosage for Product X?", our custom API endpoints would need to handle authentication for multiple systems simultaneously: the primary drug database, clinical guidelines repository, and adverse effects database. Each time we tried to set up secure API access, we hit another authentication wall. Without solving the underlying identity problem, our bot would either fail to access critical data or create security vulnerabilities.
Then there was the session management challenge. Different API endpoints required different levels of authentication based on the sensitivity of the information being accessed. Public drug information needed basic auth, while internal trial data required elevated access. We couldn't build a coherent conversation flow when our API calls kept hitting authentication timeouts or permission errors. The bot would start answering a question, then suddenly lose access mid-response when trying to cross-reference data from a different system.
But the most crucial insight came from watching employees interact with our early prototypes. We were seeing very low chat volley, and very high user drop off, two metrics that didn’t instill a lot of confidence in our approach. We found that when the bot couldn't quickly access information due to authentication barriers, users would immediately fall back to referencing outdated spreadsheets and unsecured document copies. We realized that building a successful AI assistant required solving a more fundamental problem: the fragmented identity infrastructure that was forcing employees to choose between compliance and efficiency.
The Breaking Point: When Identity Meets Innovation
The turning point came during a particularly frustrating prototype review. While something always seems to go wrong during a live demo, AIS Engage had just failed to retrieve critical drug interaction data because of an expired session token- the fourth authentication failure that hour. That moment crystallized our approach to how AIS Engage would transform login chaos into single-sign-on success. Instead of building the AI assistant and trying to work around the authentication problems, we needed to solve the identity challenge first. But not with yet another standalone solution- we needed to create an intelligent identity layer that would serve as the foundation for both current and future AI initiatives.
Our team proposed a radical shift: rather than having AIS Engage navigate the existing maze of authentication systems, we would develop a secure API gateway that would handle all the authentication complexity behind the scenes. This gateway would maintain persistent, secure connections to all required systems, managing the various authentication levels and session tokens transparently.
The pharmaceutical company's compliance team was initially skeptical. "How can you maintain security when you're essentially creating a master key?" was the main question circling the office. Our solution was to build intelligence into the identity layer itself.
Every API request would be analyzed in real-time for:
- User context and permissions
- Data sensitivity level
- Regulatory compliance requirements
- Access patterns and anomalies
This meant AIS Engage could focus on what it did best- understanding user queries and finding relevant information- while the intelligent identity layer handled the complex dance of permissions and compliance.
Inside the Innovation: Building the Intelligent Layer
The solution we devised leveraged the capabilities of our enterprise conversational AI platform while adding critical security and authentication layers to handle the complex pharmaceutical environment.
The first key element was our real-time intent analysis system. Instead of waiting for authentication failures, it analyzed user queries as they came in to determine which systems and permission levels would be needed. For example, when a user asked, "What are the contraindications for Drug X when used with chemotherapy?", our system would pre-authenticate with the drug database, prepare elevated access for clinical trial data, queue up permissions for the adverse effects database, and ready the oncology protocol system access. This predictive approach cut response times from 12-15 seconds down to under 2 seconds by eliminating cascading authentication delays.
The second element focused on conversation state management across security boundaries. Traditional approaches would lose context every time they hit a new authentication wall. Our solution maintained a secure session state across all systems, preserved conversation history with appropriate security classifications, and handled automatic re-authentication without breaking the conversation flow. This meant users could have natural, flowing conversations that seamlessly crossed security boundaries without experiencing the usual stutters and restarts that plagued earlier solutions.
The third element was our enterprise security orchestration layer, which acted as an intelligent manager for all data access. Rather than treating compliance as a yes/no checkpoint, it understood the nuanced requirements of pharmaceutical data handling. It could dynamically adjust access paths based on the user's role, location, device security status, and even time of day. When an employee asked about Phase III trial results at 9 PM from their home office, the system knew to require additional authentication steps that wouldn't be necessary during normal office hours.

Unexpected Benefits: The Authentication Insight Chain
Our data team discovered something interesting in the system logs- people weren't fighting with logins at midnight anymore. The old pattern was predictable: researchers would hit peak system usage around 2-4 PM for routine work, then another surge from 9 PM to 2 AM for those racing against deadlines. But those late-night authentication spikes had dropped by nearly half.
When we dug deeper into the numbers, we found researchers weren't leaving early- they were just working differently. Instead of bouncing between systems all day and playing catch-up at night, they were completing complex queries during normal hours. The time from question to answer had dropped from about 15 minutes to just over 2 minutes. People weren't getting locked out of systems or having to re-authenticate constantly. They'd start with basic documentation, then progressively dive deeper into more restricted data as their work required it. By understanding these patterns, we could anticipate their needs and smooth out the security checkpoints without compromising protection.
The success of this unique industry application taught us something valuable: good security isn't just about keeping things locked down, it's about understanding how people naturally work with sensitive information. Whether it's clinical trial data or 200-year-old watch schematics, experts follow surprisingly similar patterns when they need to access their most valuable knowledge.
Ladies And Gentleman: Meet The Intelligent Research Agent
We built the conversational interface to mirror how researchers naturally discuss their work. The system incorporated both vector-based retrieval and traditional knowledge base searches, allowing it to understand complex pharmaceutical queries in context. A researcher asking about "trial results from last spring" would get relevant data because the system maintained temporal awareness through API-driven date handling. The interface adapted to time of day and user context. The system tracked time zones across global research teams. The chatbot utilized NLP.
A mix of natural language processing (NLP) and other internal platform features enabled voice queries in lab environments, letting researchers ask questions while handling equipment. The system would respond through connected speakers or display results on nearby screens, maintaining strict authentication context across these different interaction modes.
The portal's visual interface featured dynamic data visualization, with carousels displaying related trial data, chemical structures, and protocol documentation. Pharmacists accessing the system received role-specific interfaces. They could quickly access drug interaction data, review trial outcomes, and cross-reference patient response patterns. The system presented this information through an intuitive hierarchy- starting with high-level safety data and drilling down to molecular details as needed.
The knowledge base grew smarter with each interaction. Frequently paired queries helped build interaction chains - if researchers often followed questions about protein binding with solubility data, the system learned to prepare this information proactively. Popular research paths became suggested workflows, helping new team members learn effective query patterns. Information retrieval adapted to user expertise was novel, but it was also fully possible for a dedicated team. Senior researchers received detailed technical data by default, while junior team members saw the same information with added context and explanatory notes. This dynamic helped train new staff while maintaining efficiency for experienced users.

AI Undercover: The Rise of Invisible Security
My favorite thing about my job at AIS is that sometimes what begins as a data access problem reveals a fundamental truth about human behavior. Maybe a controversial opinion, but when we force experts to think about security, we interrupt the natural flow of expertise- whether that's a researcher pursuing a breakthrough or a master watchmaker recreating a centuries-old mechanism. Our journey showed that the most effective security becomes invisible precisely when it matters most.
The metrics tell a compelling story about human potential. When we removed artificial authentication barriers, research efficiency didn't just improve incrementally- it transformed. The 86% reduction in context switching translated directly into deeper analytical work. Researchers who previously spent two hours per day managing system access were now spending that time advancing scientific understanding, and all we did was remove the barrier of repetitive manual task work. Even better, the system's ability to maintain security context across natural work patterns meant that protection actually improved while friction disappeared.
But the larger insight extends beyond pharmaceutical research or luxury timepieces. We discovered that expertise itself follows predictable patterns across industries. When masters of their craft- whether scientists, artisans, or physicians- engage with their domain knowledge, they move through information in sophisticated but consistent ways. By understanding these patterns, we can build security systems that protect sensitive information while becoming nearly imperceptible to legitimate users.
This realization has profound implications for the future of secure systems. Traditional security thinking focuses on barriers- who we keep out and how we verify who gets in. Our work suggests a different model: security that flows with human expertise rather than standing in its way. The authentication patterns we uncovered aren't just technical solutions; they're maps of how human knowledge naturally organizes and protects itself.
Comentaris